Jan 25, 2024 / 09:00AM GMT
Kenny Wilson Dr. Martens PLC-CEO
And thank you for joining our Q2 conference call. I'm joined here this morning by Jon Mortimore, our Chief Financial Officer; and also Bethany Barnes, our Head of Investor Relations. If you've got further questions following this call, then please do reach out to Bethany directly. So before we open it up for the Q and A session, I just wanted to take this opportunity to share my perspectives on our third quarter.
Overall, our Q3 performance was in line with the updated guidance we provided in November. This is not to say that it was an easy operating environment. Trading in the quarter was volatile with considerable regional differences and lumpiness in wholesale. The trends that we saw at Dr. Martens are broadly in line with those experienced by our peers and seen across the industry including softer December trading globally. First, there is no doubt that the consumer backdrop remains challenging particularly in the United States. We continue to focus on the levers that are within our control to drive growth and to build our product pipeline for Autumn
Q3 2023 Dr Martens PLC Trading Statement Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot